Fidia’s hair loss remedy: an update from the company


Further to previous communications, regarding the development of a hair loss remedy (aka “Brotzu lotion”) initiated several months ago, we are pleased to announce the completion of the efficacy and tolerability study, following an intensive research program.

The study was conducted productively and efficiently, to offer all patients who are affected by the problem - men and women equally - a real treatment option, effective, safe and stable.

We have successfully moved into a full-scale production, thus ensuring a smooth path to the commercial product development. The brand name chosen for Fidia’s hair loss remedy is TRINOV. An exact launch date will be defined in the next few weeks, we envisage the product will be first released in Italy by the end of 2018, other international markets will follow next.

• Completion of efficacy and tolerability study
• Full-scale production initiated
• Launch in Italy by the end of 2018


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine